β-propiolactone treatment impairs the biological activity of residual DNA from BHK-21 cells infected with rabies virus
- 31 December 1993
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 11 (1), 82-90
- https://doi.org/10.1016/0264-410x(93)90343-v
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- The protective role of humoral neutralizing antibody in the NIH potency test for rabies vaccinesVaccine, 1991
- PCR technique as an alternative method for diagnosis and molecular epidemiology of rabies virusMolecular and Cellular Probes, 1991
- Appraisal of rabies vaccine potency by determination of in vitro, specific interleukin-2 productionBiologicals, 1991
- In vitro rabies vaccine potency appraisal by ELISA: Advantages of the immunocapture method with a neutralizing anti-glycoprotein monoclonal antibodyBiologicals, 1990
- The reaction of ?-propiolactone with derivatives of adenine and with DNACarcinogenesis: Integrative Cancer Research, 1981
- Estimation of apurinic/apyrimidinic sites and phosphotriesters in deoxyribonucleic acid treated with electrophilic carcinogens and mutagensBiochemistry, 1980
- Isolation of 3-(2-carboxyethyl)thymine following in vitro reaction of β-propiolactone with calf thymus DNAChemico-Biological Interactions, 1980
- Properties of rapidly labelled deoxyribonucleic acid fragments isolated from the cytoplasm of primary cultures of embryonic mouse liver cellsJournal of Molecular Biology, 1970
- IN VIVO REACTIONS OF β‐PROPIOLACTONEAnnals of the New York Academy of Sciences, 1969
- INVESTIGATIONS OF THE USE OF BETA‐PROPIOLACTONE IN VIRUS INACTIVATION*Annals of the New York Academy of Sciences, 1960